Extracorporeal membrane oxygenation in congenital heart disease

Allen, K. Y.; Allan, C. K.; Su, L.; McBride, M. E.

Semin Perinatol. 2018 Jan 7; 42(2):104-110


This review article will discuss the indications for and outcomes of neonates with congenital heart disease who receive extracorporeal membrane oxygenation (ECMO) support. Most commonly, ECMO is used as a perioperative bridge to recovery or temporary support for those after cardiac arrest or near arrest in patients with congenital or acquired heart disease. What had historically been considered a contraindication to ECMO, is evolving and more of the sickest and most complicated babies are cared for on ECMO. Given that, it is imperative for aggressive survellience for long-term morbidity in survivors, particularly neurodevelopmental outcomes.

Read More on PubMed